Drugs / [18F]-ML-10
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00696943 | Jul 2008 → Jul 2009 | metastatic malignant neoplasm in the brain | Aposense Ltd. | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [18F]-ML-10 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00696943 ↗ |
| Modality | Diagnostic / imaging agent | “PET Imaging Radiotracer” NCT00696943 ↗ |
| Route | Intravenous | “administered as an intravenous bolus injection” NCT00696943 ↗ |